UnitedHealth Group Stock Plummets as Firm Cuts Full-Year Profit Forecasts

UnitedHealth Group Stock Plummets as Firm Cuts Full-Year Profit Forecasts

Shares of UnitedHealth Group ( UNH ) tumbled 22% Thursday morning after the healthcare giant's first-quarter results fell short of analysts' estimates and it cut its profit forecasts for 2025.

UnitedHealth reported adjusted earnings per share (EPS) of $7.20 on revenue that rose 10% year-over-year to $109.58 billion. Analysts polled by Visible Alpha had expected $7.25 and $111.46 billion, respectively.

The Eden Prairie, Minn.-based company lowered its 2025 EPS outlook to a range of $24.65 to $25.15 and its adjusted EPS projection to $26 to $26.50. Last quarter , UnitedHealth said it expected to generate full-year EPS of $28.15 to $28.65 and adjusted EPS from $29.50 to $30.00.

UnitedHealth attributed the outlook cuts to "heightened care activity indications" in its Medicare Advantage business, and "unanticipated changes in the profile of Optum Health members impacting planned 2025 reimbursement."

Analysts have said rising medical costs and lower government reimbursements for Medicare Advantage claims mean higher expenses for insurers that operate those plans like UnitedHealth, CNBC reported.

As UnitedHealth shares hit their lowest point since around the same time a year ago, shares of other health insurers like CVS Health ( CVS ), Humana ( HUM ), Elevance Health ( ELV ), and Centene ( CNC ) were dragged lower Thursday by the cost concerns.

CEO Says UnitedHealth 'Did Not Perform Up to Our Expectations'

CEO Andrew Witty said the company "did not perform up to our expectations, and we are aggressively addressing those challenges to position us well for the years ahead."

UnitedHealth shares entered the day up about 16% since the start of the year, recovering from a February slump following a report that the U.S. Department of Justice was investigating the company's diagnosing practices.

UPDATE—This article has been updated with the latest share price information and analysis.

Read the original article on Investopedia

OK